Matches in Wikidata for { <http://www.wikidata.org/entity/Q94584053> ?p ?o ?g. }
- Q94584053 description "2020 nî lūn-bûn" @default.
- Q94584053 description "2020年の論文" @default.
- Q94584053 description "2020年学术文章" @default.
- Q94584053 description "2020年学术文章" @default.
- Q94584053 description "2020年学术文章" @default.
- Q94584053 description "2020年学术文章" @default.
- Q94584053 description "2020年学术文章" @default.
- Q94584053 description "2020年学术文章" @default.
- Q94584053 description "2020年學術文章" @default.
- Q94584053 description "2020年學術文章" @default.
- Q94584053 description "2020年學術文章" @default.
- Q94584053 description "2020年學術文章" @default.
- Q94584053 description "2020年學術文章" @default.
- Q94584053 description "2020년 논문" @default.
- Q94584053 description "article científic" @default.
- Q94584053 description "article scientific" @default.
- Q94584053 description "article scientifique" @default.
- Q94584053 description "articol științific" @default.
- Q94584053 description "articolo scientifico" @default.
- Q94584053 description "artigo científico" @default.
- Q94584053 description "artigo científico" @default.
- Q94584053 description "artigo científico" @default.
- Q94584053 description "artikel ilmiah" @default.
- Q94584053 description "artikull shkencor" @default.
- Q94584053 description "artikulong pang-agham" @default.
- Q94584053 description "artykuł naukowy" @default.
- Q94584053 description "artículo científico publicado en 2020" @default.
- Q94584053 description "artículu científicu" @default.
- Q94584053 description "bilimsel makale" @default.
- Q94584053 description "bài báo khoa học" @default.
- Q94584053 description "naučni članak" @default.
- Q94584053 description "scienca artikolo" @default.
- Q94584053 description "scientific article published on 09 May 2020" @default.
- Q94584053 description "scientific article published on 9 May 2020" @default.
- Q94584053 description "scientific article published on 9 May 2020" @default.
- Q94584053 description "teaduslik artikkel" @default.
- Q94584053 description "tieteellinen artikkeli" @default.
- Q94584053 description "tudományos cikk" @default.
- Q94584053 description "vedecký článok" @default.
- Q94584053 description "vetenskaplig artikel" @default.
- Q94584053 description "videnskabelig artikel udgivet 9. maj 2020" @default.
- Q94584053 description "vitenskapelig artikkel" @default.
- Q94584053 description "vitskapeleg artikkel" @default.
- Q94584053 description "vědecký článek" @default.
- Q94584053 description "wetenschappelijk artikel" @default.
- Q94584053 description "wissenschaftlicher Artikel" @default.
- Q94584053 description "επιστημονικό άρθρο" @default.
- Q94584053 description "мақолаи илмӣ" @default.
- Q94584053 description "наукова стаття, опублікована в травні 2020" @default.
- Q94584053 description "научна статия" @default.
- Q94584053 description "научная статья" @default.
- Q94584053 description "научни чланак" @default.
- Q94584053 description "научни чланак" @default.
- Q94584053 description "מאמר מדעי" @default.
- Q94584053 description "مقالة علمية نشرت في 9 مايو 2020" @default.
- Q94584053 description "৯ মে ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q94584053 description "บทความทางวิทยาศาสตร์" @default.
- Q94584053 description "სამეცნიერო სტატია" @default.
- Q94584053 name "Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib" @default.
- Q94584053 name "Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib" @default.
- Q94584053 type Item @default.
- Q94584053 label "Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib" @default.
- Q94584053 label "Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib" @default.
- Q94584053 prefLabel "Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib" @default.
- Q94584053 prefLabel "Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib" @default.
- Q94584053 P1433 Q94584053-5F616D4C-5E72-491A-81DB-FA7DF98FC7F3 @default.
- Q94584053 P1476 Q94584053-6ECB9B1E-115B-44A8-9F0A-87CCB7C94202 @default.
- Q94584053 P2093 Q94584053-0C8670A3-457E-4E0C-A338-533BC11831D7 @default.
- Q94584053 P2093 Q94584053-26BF93C7-A7CD-491A-9EB2-09A04A9EE394 @default.
- Q94584053 P2093 Q94584053-3F803131-41E1-43EF-8B4A-670932F42B86 @default.
- Q94584053 P2093 Q94584053-66AC568B-A4AC-491C-8C84-51E9DA13D1C6 @default.
- Q94584053 P2093 Q94584053-6ADF5DBE-2B94-4A0B-84D8-8599E2BF35AD @default.
- Q94584053 P2093 Q94584053-7602E3CC-047B-4528-9C7D-C72F2FF21DED @default.
- Q94584053 P2093 Q94584053-7A551F93-2D7E-45AB-ACAC-FD4E1B7A39AE @default.
- Q94584053 P2093 Q94584053-7AF5F969-7345-4504-B856-DD0E4BD059E2 @default.
- Q94584053 P2093 Q94584053-8136A3C0-3BEF-40AF-92F4-1FC94EF6C0FE @default.
- Q94584053 P2093 Q94584053-83C52E25-1F6C-438E-9387-7462F2790B28 @default.
- Q94584053 P2093 Q94584053-883FA01D-9FE5-4FA6-B8C7-B231E9551B61 @default.
- Q94584053 P2093 Q94584053-A5593C28-4DDF-4164-890D-68BBE28A64B2 @default.
- Q94584053 P2093 Q94584053-B5DE9810-CA13-47BD-BA53-F3BF3DE563FF @default.
- Q94584053 P2093 Q94584053-BDB18B05-3482-4C60-A959-060ED645E21C @default.
- Q94584053 P2093 Q94584053-D4F019EB-29E3-4BF5-8E47-78FE9437CAE1 @default.
- Q94584053 P2093 Q94584053-D9C370E8-CE9A-4DB1-A21F-D7BAD40C3CF7 @default.
- Q94584053 P2093 Q94584053-FA16853D-7A12-4CC1-B972-667FF7BA6743 @default.
- Q94584053 P31 Q94584053-F3929A5B-EB0B-4111-8151-BCCE692B7DE6 @default.
- Q94584053 P356 Q94584053-5EF1CCF4-77EB-4D74-97F0-7B19DE3EFEA1 @default.
- Q94584053 P50 Q94584053-2E80CA42-DA9A-4542-9BAD-A3C5E1A4AF3C @default.
- Q94584053 P577 Q94584053-67A59F87-E845-47BF-A484-4D764030050F @default.
- Q94584053 P698 Q94584053-2789A845-EE3E-4147-9078-6DCC8AAA2FF2 @default.
- Q94584053 P932 Q94584053-9D7C6453-FC09-46AF-8187-9745A7B0FE4C @default.
- Q94584053 P356 THEONCOLOGIST.2020-0088 @default.
- Q94584053 P698 32386255 @default.
- Q94584053 P1433 Q2122327 @default.
- Q94584053 P1476 "Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib" @default.
- Q94584053 P2093 "Bin-Chi Liao" @default.
- Q94584053 P2093 "Chao-Chi Ho" @default.
- Q94584053 P2093 "Chen-Tu Wu" @default.
- Q94584053 P2093 "Chia-Chi Hsu" @default.
- Q94584053 P2093 "Chia-Chi Lin" @default.
- Q94584053 P2093 "Chia-Lin Hsu" @default.